You are hereMay 8, 2012
Life Technologies Expands Cell Culture Production Facility
The facility will produce GIBCO® cell culture products used for biological drug research, development and production. The company expects to break ground at the site in 2013 and to ship product from the facility beginning in 2014.
Life Technologies produces more than 50,000 products for translational research, molecular medicine and diagnostics, stem cell-based therapies, forensics, food safety and animal health. It currently holds more than 4,000 patents and exclusive licenses. In 2011 sales totaled US $3.7 billion.